Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NeuroPsyCAD

Financiado

Cerrado

Artificial Intelligence for early and accurate neuropsychiatric diagnosis

NeuroPsyCAD is a cloud-based reporting service that provides an accurate and early diagnosis of neuropsychiatric disorders. To achieve high accuracies, NeuroPsyCAD statistically compares a brain scan of a patient with a normative,... ver más

31/05/2018

NeuroPsyAI

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

NEUROPSYAI SERVICOS E INVESTIGACAOEM NEUROCIE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-05-31

SMEInst-01-2016-2017: Open Disruptive Innovation Scheme

I+D

Cerrada hace 9 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

NeuroPsyAI

50.00K€ | Lider

Proyectos interesantes

MULTI-LAND

Medical Technol...

Data Science

224K€ Cerrado

Neurocloud

Medical Technol...

Software

71K€ Cerrado

PID2019-104358RB-I00

Medical Technol...

Data Science

49K€ Cerrado

FJC2021-046498-I

Medical Technol...

Data Science

65K€ Cerrado

OSCANN

Medical Technol...

Artificial Inte...

71K€ Cerrado

MES-CoBraD

Medical Technol...

Data Science

6M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 6 meses Fecha Inicio: 2017-11-24
Fecha Fin: 2018-05-31

Líder del proyecto

NEUROPSYAI SERVICOS E INVESTIGACAOEM NEUROCIE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto NeuroPsyCAD is a cloud-based reporting service that provides an accurate and early diagnosis of neuropsychiatric disorders. To achieve high accuracies, NeuroPsyCAD statistically compares a brain scan of a patient with a normative, human, and population representative database using machine-learning algorithms. It also analyses the brain as a whole and the connections between its parts to define patterns of changes in the brain related to each disorder (and can integrate information from different image sources, if needed). Finally, it can integrate information from different imaging sources. The NeuroPsyCAD’s target market are patients that come to clinical services with one of the following neuropsychiatric diseases: Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Schizophrenia Spectrum Disorder (SSD), or Autism Spectrum Disorder (ASD). NeuroPsyCAD’s worldwide total market is 130 million. This value takes into account the worldwide total number of patients having one of the four diseases. Te annual excess spend for Alzheimer’s and Parkinson’s patients is €10,000 per year due to misdiagnosis which occur in about 17% of cases. Multiplying this by the number of new patients per year in the US and EU, results in a cost of €2.3 billion per year that can be saved by using NeuroPsyCAD. Additionally, studies show that early treatment of Alzheimer’s Disease patients delay institutionalization and generates further savings of also about €10,000 per patient . NeuroPsyAl is a new innovative spin-off start-up from the Institute of Biophysics and Biomedical Engineering and at the Institute of Molecular Medicine, of the University of Lisbon, Portugal. Whilst we incorporated in May 2017 after all the relevant IP was transferred to us from IBEB and iMM Lisboa, we started to create our core and only product NeuroPsyCAD in 2012.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores